By ANDY OBER InsideINdianaBusiness INDIANAPOLIS — Indianapolis-based Eli Lilly and Co. says the diabetes treatment Jardiance met its primary endpoint in a latest clinical trial. The company says the treatment lowered cardiovascular risk in adults with type 2 diabetes. Lilly says the long-term trial involved more than 7,000 patients from 42 countries. at high risk …read more.